Q3 2014: Top Life Science VC Deals in San Diego

October 21, 2014

More »

Otonomy Named in FierceBiotech's List of 2014's Most Successful Biotech IPOs

October 15, 2014

More »

How a U.S. VC firm keeps doing business with Russia (Fortune)

October 1, 2014

Fortune interviews partner Jim Blair about Domain’s partnership with Rusnano, a government-owned investment fund in Russia.
More »

When Funds Flow (SDBJ)

September 15, 2014

Biotechs Still Eyeing IPOs; VC Backing Is Strong in 2nd Quarter. Jim Blair talks about the strongest second quarter nationally since at least 1995.
More »

Bringing Disruptive Innovations to Market (GEN)

June 26, 2014

Kim Kamdar gives Genetic Engineering & Biotechnology News her VC opinion on funding the drug pipeline at the BIO 2014 panel discussion “Translating Disruptive Innovations into Products: Successfully Blazing New Trail in Stem Cells, RNA, and Epigenetics-based Therapeutics”.
More »